HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Vident Investment Advisory LLC

Vident Investment Advisory LLC raised its position in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,856 shares of the company’s stock after purchasing an additional 472 shares during the period. Vident Investment Advisory LLC’s holdings in HCA Healthcare were worth $9,489,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Mount Yale Investment Advisors LLC lifted its stake in HCA Healthcare by 5.3% during the first quarter. Mount Yale Investment Advisors LLC now owns 5,178 shares of the company’s stock worth $1,298,000 after purchasing an additional 259 shares during the last quarter. CI Investments Inc. raised its stake in shares of HCA Healthcare by 51.6% during the first quarter. CI Investments Inc. now owns 18,788 shares of the company’s stock valued at $4,709,000 after purchasing an additional 6,392 shares in the last quarter. CVA Family Office LLC raised its stake in shares of HCA Healthcare by 31.5% during the first quarter. CVA Family Office LLC now owns 605 shares of the company’s stock valued at $152,000 after purchasing an additional 145 shares in the last quarter. Commerce Bank raised its stake in shares of HCA Healthcare by 6.1% during the fourth quarter. Commerce Bank now owns 6,859 shares of the company’s stock valued at $1,762,000 after purchasing an additional 392 shares in the last quarter. Finally, Machina Capital S.A.S. acquired a new position in HCA Healthcare during the first quarter worth about $226,000. 65.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Bank of America raised their price objective on HCA Healthcare from $192.00 to $230.00 in a research report on Sunday, July 24th. Sanford C. Bernstein raised HCA Healthcare from a “market perform” rating to an “outperform” rating and dropped their price target for the stock from $273.00 to $271.00 in a research report on Thursday, May 26th. SVB Leerink boosted their price objective on HCA Healthcare from $240.00 to $259.00 and gave the company an “outperform” rating in a research report on Wednesday, August 24th. UBS Group boosted their price objective on HCA Healthcare to $227.00 in a research report on Tuesday, July 26th. Finally, The Goldman Sachs Group lowered their price target on HCA Healthcare from $270.00 to $233.00 and set a “buy” rating on the stock in a research report on Tuesday, July 12th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $237.71.

HCA Healthcare Stock Performance

NYSE:HCA opened at $219.70 on Friday. The stock has a market cap of $63.06 billion, a P/E ratio of 10.57, a PEG ratio of 1.62 and a beta of 1.72. The stock has a 50 day simple moving average of $199.21 and a 200 day simple moving average of $217.70. The company has a current ratio of 1.55, a quick ratio of 1.32 and a debt-to-equity ratio of 87.46. HCA Healthcare, Inc. has a 1-year low of $164.47 and a 1-year high of $279.02.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings results on Friday, July 22nd. The company reported $4.21 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The business had revenue of $14.82 billion during the quarter, compared to analysts’ expectations of $14.73 billion. During the same period last year, the firm posted $4.37 EPS. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. Research analysts anticipate that HCA Healthcare, Inc. will post 17.1 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 16th will be paid a $0.56 dividend. The ex-dividend date is Thursday, September 15th. This represents a $2.24 annualized dividend and a dividend yield of 1.02%. HCA Healthcare’s payout ratio is 10.77%.

Insider Activity at HCA Healthcare

In other news, major shareholder Patricia F. Elcan bought 325 shares of the firm’s stock in a transaction that occurred on Monday, July 25th. The stock was acquired at an average cost of $198.66 per share, with a total value of $64,564.50. Following the transaction, the insider now directly owns 89,337 shares of the company’s stock, valued at approximately $17,747,688.42. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.